T

T2 Biosystems

D
TTOO
USD
0.029
(4.1968%)
Market Closed
7,191.00
Volume
-4.38
EPS
-
Div Yield
0.024242
P/E
12,585,566.88
Market Cap
Today
4.1968%
1 Week
-17.479%
1 Month
-55.556%
6 Months
-77.778%
12 Months
-86.740%
Year To Date
-88.535%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ABT
ABT
-1.475
(-1.263%)
USD
BDX
BDX
-13.09
(-5.4521%)
USD
B
BAX
-0.07
(-0.1938%)
USD
BSX
BSX
0.45
(0.5205%)
USD
EW
EW
0.09
(0.1369%)
USD
ISRG
ISRG
4.01
(0.7705%)
USD
MDT
MDT
-1.99
(-2.2084%)
USD
Z
ZBH
-2.495
(-2.244%)
USD
A
ALGN
2.28
(1.0359%)
USD
W
WST
-5.93
(-1.8018%)
USD

Title:
T2 Biosystems

Sector:
Healthcare
Industry:
Diagnostics & Research
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Do you need help or have a question?
Contact Us